# Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence

> **NCT01609842** · NA · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 14573 (actual)

## Conditions studied

- Cardiovascular Disease
- Acute Coronary Syndrome

## Interventions

- **OTHER:** Multifaceted Intervention with pharmacist and IVR

## Key facts

- **NCT ID:** NCT01609842
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-20
- **Primary completion:** 2018-03-01
- **Final completion:** 2022-02-07
- **Target enrollment:** 14573 (ACTUAL)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609842, "Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01609842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*